Acute kidney injury due to anti-tuberculosis drugs: A five-year experience in an aging population

Chia Hao Chang, Yen Fu Chen, Vin Cent Wu, Chin Chung Shu, Chih Hsin Lee, Jann Yuan Wang, Li Na Lee, Chong Jen Yu

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)


Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population. This study aimed to calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes and predictors of renal recovery.Methods: From 2006 to 2010, patients on anti-TB treatment were identified and their medical records reviewed. Acute kidney injury was defined according to the criteria established by the AKI Network, while renal recovery was defined as a return of serum creatinine to baseline. Predictors of renal recovery were identified by Cox regression analysis.Results: Ninety-nine out of 1394 (7.1%) patients on anti-TB treatment had AKI. Their median age was 68 years and there was male predominance. Sixty (61%) developed AKI within two months of anti-TB treatment, including 11 (11%) with a prior history of rifampin exposure. Thirty (30%) had co-morbid chronic kidney disease or end-stage renal disease. The median time of renal recovery was 39.6 days (range, 1-180 days). Factors predicting renal recovery were the presence of fever, rash, and gastro-intestinal disturbance at the onset of AKI. Sixty-two of the 71 (87%) patients who recovered from AKI had successful re-introduction or continuation of rifampin.Conclusions: Renal function impairment is not a rare complication during anti-TB treatment in an elderly population. The presence of fever and rash may be associated with renal recovery. Rifampin can still be used in most patients who recover from AKI.

Original languageEnglish
Article number23
JournalBMC Infectious Diseases
Issue number1
Publication statusPublished - Jan 13 2014
Externally publishedYes


  • Acute kidney injury
  • Anti-tuberculosis drug
  • Fever
  • Rash
  • Rifampin

ASJC Scopus subject areas

  • Infectious Diseases


Dive into the research topics of 'Acute kidney injury due to anti-tuberculosis drugs: A five-year experience in an aging population'. Together they form a unique fingerprint.

Cite this